SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-043974
Filing Date
2021-08-12
Accepted
2021-08-12 16:11:59
Documents
80
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q kdny-10q_20210630.htm   iXBRL 10-Q 3430703
2 EX-10.24 kdny-ex1024_212.htm EX-10.24 101709
3 EX-31.1 kdny-ex311_6.htm EX-31.1 21123
4 EX-31.2 kdny-ex312_8.htm EX-31.2 21416
5 EX-32.1 kdny-ex321_7.htm EX-32.1 8134
  Complete submission text file 0001564590-21-043974.txt   11719360

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA kdny-20210630.xsd EX-101.SCH 65283
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kdny-20210630_cal.xml EX-101.CAL 69004
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kdny-20210630_def.xml EX-101.DEF 187484
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE kdny-20210630_lab.xml EX-101.LAB 481922
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kdny-20210630_pre.xml EX-101.PRE 382035
11 EXTRACTED XBRL INSTANCE DOCUMENT kdny-10q_20210630_htm.xml XML 2475851
Mailing Address 1600 FAIRVIEW AVE E. SEATTLE WA 98102
Business Address 1600 FAIRVIEW AVE E. SEATTLE WA 98102 206-485-7051
CHINOOK THERAPEUTICS, INC. (Filer) CIK: 0001435049 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37345 | Film No.: 211167669
SIC: 2834 Pharmaceutical Preparations